featured research

brain illustration

AstraZeneca, VU collaborate to develop new treatments for major brain disorders

AstraZeneca and Vanderbilt University have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia.

Simulated Mars mission reveals body’s sodium rhythms

Clinical pharmacologist Jens Titze, M.D., and colleagues have discovered that – in contrast to the prevailing dogma – human sodium levels fluctuate rhythmically with 7-day and monthly cycles.

medical lab

Vice Chancellor Balser: ‘Cliff’ looming for biomedical research

“Beyond the damaging effects on the health of our people, disrupting the nation’s biomedical science infrastructure puts our economic future at risk,” writes Vice Chancellor for Health Affairs Jeff Balser in The Tennessean.

Children's Hospital exterior

Improved patient ‘handover’ process bolsters outcomes

Patient handovers matter. A lot. That’s the conclusion from Vanderbilt researchers who reviewed three years of patient data and found that major complications occurring within 24 hours after cardiac surgery were cut in half following the adoption of an improved handover process.

neurons

VU scientists cheer Nobel Prize for stem cell research

Vanderbilt University scientists are cheering this year’s Nobel Prize in Medicine for recognizing the discovery that mature cells can be “reprogrammed” into other cell types — a finding which they said has electrified their work.

insurance card

Study tracks potential coverage gaps under Affordable Care Act

An analysis of Massachusetts’ health care reform program by a Vanderbilt researcher indicates insurance gaps may remain as the Affordable Care Act (ACA) expands insurance coverage beginning in 2014.

1 6 7 8 9 10 12